Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

First of all it's not sitting at a dime and secondly don't you have to actually own stock in the company to use the collective term "we".

Here's my latest post on one of the comments sections on Yahoo:

Sometimes the best opportunity for substantial profits is to invest in little known companies that have big potential before the market discovers them.

One of these companies is Amarantus Bioscience - AMBS- which is currently trading under 11 cents.

The company will be launching the first diagnostic blood test, LymPro, to detect early stage Alzheimer's this year. It's currently working with Becton Dickinson. The company is in the process of finalizing a partnership to market the test.

The recent Chairman's blog will give you a good overview of the company's potential with numerous other products in its pipeline and it discusses the planned up-listing to the NASDAQ this year:

http://www.thechairmansblog.com/amarantus-bioscience/gerald-commissiong/2h-2014-milestones-ahead-position-amarantus-list/?utm_source=rss&utm_medium=rss&utm_campaign=2h-2014-milestones-ahead-position-amarantus-list

On Friday the company announced that it has entered into a research collaboration with the Washington University School of Medicine in St. Louis to evaluate the efficacy of the company's patented drug, MANF, to treat Wolfram-Syndrome in the field of diabetes.

http://finance.yahoo.com/news/amarantus-enters-wolframs-research-collaboration-132700921.html

Take the time to research the company before it's discovered by the market.

Twitter: @AmarantusBio .... 10,000+ followers.